Skip to main content
Year archive

SAMSUNG PHARMACEUTICAL.CO.,Ltd. — 2025 filings

All 20 regulatory filings released by SAMSUNG PHARMACEUTICAL.CO.,Ltd. (001360) in 2025, sourced directly from the official regulator.

20 Filings
2025 Period
2025 filings (20)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-12-18 Korean
[기재정정]타법인주식및출자증권취득결정
Capital/Financing Update
2025-11-11 Korean
[기재정정]타법인주식및출자증권취득결정
Capital/Financing Update
2025-10-24 Korean
타법인주식및출자증권취득결정
Capital/Financing Update
2025-10-02 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2025-08-25 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2025-08-22 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change
2025-08-21 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2025-08-20 Korean
[기재정정]사업보고서 (2024.12)
Annual Report FY 2024
2025-08-14 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-14 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2025-08-08 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-15 Korean
정기주주총회결과 (제 71기)
Declaration of Voting Results & Voting Rights Announcements
2025-03-27 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-19 Korean
사업보고서 (2024.12)
Audit Report / Information FY 2024
2025-03-19 Korean
주주총회소집결의
AGM Information
2025-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-12 Korean
주주총회집중일개최사유신고
AGM Information
2025-03-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2024
2025-02-10 Korean